Thiazolidinediones vs no intervention
Serious adverse events (number of events) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether thiazolidinediones changes serious adverse events (number of events) compared with no intervention (very low certainty).
1 finding from 1 review
- Pharmacological interventions for non‐alcohol related fatty liver disease (NAFLD) 2017 · Cochrane Headline outcomes onlyrate ratio 0.25 [0.06, 1.05]3 studies · 357 participantsVery low